Quantib and QMENTA, two innovators in the field of neuroimaging, have decided to bring their forces together to build the first decision support system for stroke. Their aim is to optimize clinical decision-making by supporting accurate diagnosis of ischemic or hemorrhagic stroke in the acute stage, thus improve the patient outcome. To achieve this, they will be using state-of-the-art machine learning and deep learning techniques with Quantib's biomarkers on QMENTA's advanced platform in order to provide objective, automated, and quantitative analysis of CT brain scans.
Quantib® Brain provides white matter hyperintensity and brain tissue quantification. It offers a tool to objectively assess brain changes in longitudinal exams in neurodegenerative disease.
Quantib® Brain allows you to download the examination results in a comprehensive report including self-selected cross-sections and personal comments.